Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

android tablet pc

Home > Press > Vaginal gel with bee venom lowers transmission of HIV

A recent discovery that a vaginal gel consisting of nanoparticles carrying bee venom can serve both for contraception and for HIV prevention won a grant from the Gates Foundation.

by Jack Marshall Staff Reporter

Vaginal gel with bee venom lowers transmission of HIV

Saint Louis, MO | Posted on November 19th, 2010

The gel is especially promising for improving sexual health because it caters to women. This differs from condoms, which have been the number-one choice to prevent the spread of HIV but depend heavily on male participation and willingness to use them.

"This gel gives women an opportunity to empower themselves to prevent HIV and pregnancy with a product they can use themselves," said Bradley Stoner, associate professor of anthropology.

The idea came from Sam Wickline, a professor of medicine, cell biology and physiology at the Washington University School of Medicine. Wickline is one of 65 scientists to participate in the 2010 Grand Challenges Explorations Grant program, a $100 million program sponsored by the Bill & Melinda Gates Foundation.

The Grand Challenges Explorations Grant traditionally rewards projects that result from unorthodox thinking and innovative ideas to aid in the fight against global health problems.

"Sperm and HIV are remarkably similar in their natural mechanism of genetic transmission," Wickline said in a news release. "Both need to fuse with their target cell in order to deliver their genetic payloads—DNA in the case of sperm, and RNA in the case of HIV."

And even though the gel is not as familiar to people as are condoms, Stoner thinks that people can be educated easily about its use.

"There have been some recent trials of intravaginal microbicide gels that prevent against HIV and other STDs, and they've been found to be well accepted by women, so this is also something that could be implemented probably with great success," Stoner said.

Though research on the gel is still in early stages, Stoner hopes that the gel will be affordable.

"If researchers are able to prove that this works and that it can be manufactured on a large scale, I hope that price would go down to supportable levels," Stoner said.

According to Wickline, the gel contains a "Trojan Horse," a lipid nanoparticle developed by Wickline and Gregory Lanza, a professor of medicine, biomedical engineering, and biology and biomedical sciences at the medical school, that attracts the sperm and HIV before destroying it using the bee toxin.

"The idea is to trick each [agent] to fuse with a synthetic Trojan horse—a nanoparticle that will overwhelm sperm and HIV in numbers and in destructive power," Wickline said.

The bee toxin, known as melittin, comes from the honeybee Apis mellifera. The method has been shown to be safe for clinical use.

"Cells readily take in melittin," Wickline said. "But once it gets in, it pokes holes in cell membranes to destroy the cells."

The Gates Foundation launched the Grand Challenges Explorations Grant program in 2003 as a way to find new solutions to health problems that have not been solved adequately by traditional means. Scientists can apply for the Explorations program online and receive news about whether their idea has been chosen for a $100,000 grant approximately four months after the submission deadline. The foundation gives grants of $100,000 twice a year, while successful projects can receive an additional grant of $1 million and become part of the Grand Challenges project, as Wickline's project has. According to the Grand Challenges website, the Gates Foundation has given grants to 405 researchers from 34 countries.

Projects this year include another HIV vaginal contraceptive, developed by Nongnuj Tanphaichitr of the Ottawa Health Research Institute, which, according to the Grand Explorations website, will "research whether the antimicrobial peptide LL-37 can be used simultaneously as a contraceptive and an anti-HIV treatment."

In addition to Tanphaichitr's and Wickline's projects, 17 other projects fall under the "Create New Technologies for Contraception" topic. The 65 projects, announced on Nov. 9 as winners of Grand Challenges Explorations grants, fall under 12 categories.

"We believe this can succeed because both sperm and HIV are built to target, fuse and discharge their cargo," Wickline said in the news release. "Our nanoparticles are similarly built to target, fuse and deliver their cargo. These attributes will enable a process of mutual assured destruction in a sequestered biological environment."


For more information, please click here

Copyright © Washington University in St. Louis

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Lifeboat Foundation Responds to Largest Ebola Outbreak in History October 2nd, 2014

Iran's Sharif University to Host 4th Conference on Nanostructured Solar Cells October 2nd, 2014

Multifunctional Cotton Fabrics Produced in Iran Using Nanotechnology October 2nd, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Possible Futures

Lifeboat Foundation Responds to Largest Ebola Outbreak in History October 2nd, 2014

Air Force’s 30-year plan seeks 'strategic agility' August 1st, 2014

IBM Announces $3 Billion Research Initiative to Tackle Chip Grand Challenges for Cloud and Big Data Systems: Scientists and engineers to push limits of silicon technology to 7 nanometers and below and create post-silicon future July 10th, 2014

Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014


Yale University and Leica Microsystems Partner to Establish Microscopy Center of Excellence: Yale Welcomes Scientists to Participate in Core Facility Opening and Super- Resolution Workshops October 20 Through 31, 2014 September 30th, 2014

Rice launches Center for Quantum Materials: RCQM will immerse global visitors in cross-disciplinary research September 30th, 2014

Biosensors Get a Boost from Graphene Partnership: $5 Million Investment Supports Dozens of Jobs and Development of 300mm Fabrication Process and Wafer Transfer Facility September 18th, 2014

Malvern technology delivers Malvern reliability in multi-disciplinary lab at Queen Mary University London September 9th, 2014


Arrowhead Expands Management Team with Appointment of Susan Boynton as Vice President Global Regulatory Affairs October 1st, 2014

Nanobotmodels present metastasis and angiogenesis medical animation October 1st, 2014

'Stealth' nanoparticles could improve cancer vaccines October 1st, 2014

New Absorber Will Lead to Better Biosensor: Biosensors are more sensitive and able to detect smaller changes in the environment October 1st, 2014


Lifeboat Foundation Responds to Largest Ebola Outbreak in History October 2nd, 2014

Iran's Sharif University to Host 4th Conference on Nanostructured Solar Cells October 2nd, 2014

Multifunctional Cotton Fabrics Produced in Iran Using Nanotechnology October 2nd, 2014

Graphene chips are close to significant commercialization October 1st, 2014

Personal Care

Sunblock poses potential hazard to sea life August 20th, 2014

AQUANOVA receives Technology Leadership Award 2014 FROST & SULLIVAN honors NovaSOL® Technology again August 12th, 2014

Nanotechnology used in sunscreens: a Mexican achievement May 14th, 2014

Production of Nanocapsule from Sea-Buckthorn Extract in Iran May 3rd, 2014


$18-million NSF investment aims to take flat materials to new heights: 2-D alternatives to graphene may enable exciting advances in electronics, photonics, sensors and other applications October 1st, 2014

A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014

Teijin Aramid’s carbon nanotube fibers awarded with Paul Schlack prize: New generation super fibers bring wave of innovations to fiber market September 25th, 2014

New chip promising for tumor-targeting research September 22nd, 2014


Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014

How things coil: Researchers discover that simulation technology designed for Hollywood can be used as a predictive tool for understanding fundamental engineering problems September 29th, 2014

Penn Team Studies Nanocrystals by Passing Them Through Tiny Pores September 26th, 2014

New NIH/DOE Grant for Life Science Studies at NSLS-II: Funding will support operation of three powerful experimental stations designed to reveal detailed structures of proteins, viruses, and more September 23rd, 2014

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE